Clinical Outcomes of Newborns Born to Pregnant Women With and Without COVID-19

NCT ID: NCT04883801

Last Updated: 2021-05-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

202 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-11

Study Completion Date

2021-05-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A case-control trial was conducted to test the early postpartum period clinical outcomes of newborns born to pregnant women with and without COVID-19.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19 Vertical Transmission of Infectious Disease Neonatal Infection Pregnancy Related

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COVID-19 case group

Newborns born to pregnant women diagnosed with COVID-19 during hospitalization for delivery

Reviewed clinical records and laboratory results

Intervention Type DIAGNOSTIC_TEST

Retrospectively reviewed clinical records and laboratory results

Control group

Newborns born to pregnant women who were not diagnosed with COVID-19 in their medical history and hospitalization for delivery

Reviewed clinical records and laboratory results

Intervention Type DIAGNOSTIC_TEST

Retrospectively reviewed clinical records and laboratory results

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Reviewed clinical records and laboratory results

Retrospectively reviewed clinical records and laboratory results

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Pregnant women on labor or preterm labor. Pregnant women who underwent programmed or emergence cesarean

Exclusion Criteria

Those who were transferred to another hospital without or within a short period of delivery
Minimum Eligible Age

19 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kahramanmaras Sutcu Imam University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Deniz Akyıldız

Assistant professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Denizli State Hospital

Denizli, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Newborns outcomes

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Vaccination Hesitation in Expectant Mothers
NCT06530875 ENROLLING_BY_INVITATION NA